179. Deputy Caoimhghín Ó Caoláin asked the Minister for Health in view of the fact that the ESRI report, Delivery of Pharmaceuticals in Ireland - Getting a Bigger Bang for the Buck, published in January 2012, stated that prices of new pharmaceuticals, subject to patent protection, could be reduced further by setting the ex-factory price with reference to the lowest-priced comparator member state and that an examination of data from recent years suggests prices would decline by 20% to 25% if such an approach were adopted, to quantify the savings which could be made by introducing this measure with immediate effect; and if he will make a statement on the matter. [30463/14]

Summary

179. Deputy Caoimhghín Ó Caoláin asked the Minister for Health in view of the fact that the ESRI report, Delivery of Pharmaceuticals in Ireland - Getting a Bigger Bang for the Buck, published in January 2012, stated that prices of new pharmaceuticals, subject to patent protection, could be reduced further by setting the ex-factory price with reference to the lowest-priced comparator member state and that an examination of data from recent years suggests prices would decline by 20% to 25% if such an approach were adopted, to quantify the savings which could be made by introducing this measure with immediate effect; and if he will make a statement on the matter. [30463/14]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Prices

  xml · EN · 10 July 2014

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.